Forget Crypto. Invest in You.
By Kimlyn Queen-Weis, CRA, FAHRA, MS, MBA, 2021-2022 President, AHRA.
Connecting medical imaging leaders to the latest industry news, best practices, and AHRA happenings.
By Kimlyn Queen-Weis, CRA, FAHRA, MS, MBA, 2021-2022 President, AHRA.
From AHRA Regulatory Affairs Committee, with permission by Tom Greeson/Reed Smith In April, GE Healthcare issued an alert to its
Get to know the latest AHRA Director candidates. Elections will take place May 2-16, 2022 online at http://www.ahra.org.
By Kimlyn Queen-Weis, CRA, FAHRA, MS, MBA, 2021-2022 President, AHRA.
Congratulations to the 2022 RACC Commissioners!
By Kimlyn Queen-Weis, CRA, FAHRA, MS, MBA, 2021-2022 President, AHRA.
Episode 10, “Theranostics: Responding to its Resurgence,” by Lyle Wilson and Steve Sosnowski. Overall theranostic agents are rapidly changing nuclear medicine departments importance by forcing them to be more multidisciplined, working with other departments in the hospital (radiation oncology, interventional radiology, endocrinology, pharmacy, etc), and have the potential of dramatically increasing reimbursement. This has raised the profile of an imaging modality that has thought to have stagnated. However, it has also placed high demands on staff as the workflow for these treatments and imaging studies are very different, and can be demanding in terms of time and safety.
Here, we warmly welcome new members, and recognize any recent successes among members. If you would like to acknowledge a colleague, announce a promotion, or make us aware of an accomplishment please let us know.